Feasibility of Mindfulness Meditation Training and Home Practice in Persons With Spinal Cord Injury

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Recruiting
CT.gov ID
NCT05556057
Collaborator
National Center for Complementary and Integrative Health (NCCIH) (NIH), Sam Houston State University (Other), TIRR Memorial Hermann (Other)
60
2
2
22.8
30
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the feasibility and acceptability of a 6-week app-guided Mindfulness meditation training (MM) intervention and health education (active control) condition in people with spinal cord injury (SCI) who have chronic pain and to examine the feasibility of data collection procedures

Condition or Disease Intervention/Treatment Phase
  • Other: mindfulness meditation(MM)
  • Other: Health Education (active control)
N/A

Detailed Description

Our multidisciplinary, interinstitutional team of investigators proposes to randomize 60 SCI patients experiencing chronic pain to practice audio-guided MM for ≥ 10 minutes daily for 6 weeks using the free app "Mindfulness Coach" developed by the Department of Veteran Affairs, or to listen or view health education presentations (active control) ≥ 10 minutes daily for 6 weeks on the free TED app (active control). Primary outcomes are the feasibility and acceptability of proposed interventions in people with SCI and chronic pain. Secondary outcomes include the feasibility of collecting patient-reported outcomes of pain, anxiety, depression, mindfulness, quality of life, stress, fatigue and sleep disturbance.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Other
Official Title:
Feasibility of Mindfulness Meditation Training and Home Practice in Persons With Spinal Cord Injury: A Pilot Study
Actual Study Start Date :
Dec 6, 2022
Anticipated Primary Completion Date :
Jul 15, 2024
Anticipated Study Completion Date :
Oct 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: mindfulness meditation(MM)

Other: mindfulness meditation(MM)
Participants will be provided with a unique invitation code that will allow them to download and use the free research version of the Mindfulness Coach app that is designed to deliver mindfulness training developed by the Veteran Affairs' National Center for PTSD.The app is tailored to users who may be skeptical about meditation practices by providing simple instructions and brief meditation exercises. The app offers written information about mindfulness as well as 12 audio-guided meditations each lasting 8-13 minutes, with an average length of 10 minutes

Active Comparator: Health Education

Other: Health Education (active control)
Participants will be asked to download and use the free TED Talk app.Each participant's account will include a list of over 80 TED Talks related to the six broad categories of sleep, nutrition, mood, relationships, chronic pain, and health behaviors. These talks range from 4 to 18 minutes and were reviewed/selected by the investigator team. The research coordinator(RC) will instruct them to watch or listen to these videos for ≥ 10 minutes daily for 6 days per week. The RC will ask participants to complete weekly logs of their TED Talk app use

Outcome Measures

Primary Outcome Measures

  1. Feasibility as assessed by the proportion of eligible people who provide consent [end of study at 3 years]

  2. Feasibility as assessed by the number of participants who complete the minimum recommended minutes (i.e., 60 minutes/per week) of using the MM or HE app during the 6 weeks intervention [post-intervention (6 weeks post-enrollment)]

  3. Feasibility as assessed by the number of participants that complete all visits [end of study (12 weeks post enrollment)]

    Visits include baseline, immediate post-intervention and 6-week follow-up assessments.

  4. Acceptability as assessed by the patient-reported program evaluation questionnaire scale [post-intervention (6 weeks post-enrollment)]

    This questionnaire has 12 questions each is scored form 1(no, definitely not) to 4(yes definitely), a higher score indicating more acceptability. The questionnaire also has 5 open ended questions where the subject can enter any recommendations to improve the app.

Secondary Outcome Measures

  1. Feasibility of collecting patient reported outcomes of pain as assessed by the International SCI pain basic data subset (version 2) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This survey contains 11 questions and each one is measured from 0(no pain) to 10(chronic pain),with a maximum score of 110, a higher number indicating more pain

  2. Feasibility of collecting patient reported outcomes of pain-related distress as assessed by the Chronic Pain Acceptance Questionnaire (CPAQ-R8) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This is a 20 item questionnaire,each is scored from 0(never true) to 6(always true), a higher number indicating higher acceptance

  3. Feasibility of collecting patient reported outcomes of brief pain as assessed by the Brief Pain Catastrophizing Scale (Brief PCS) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This measures three aspects of catastrophic cognitions about pain-rumination, magnification, and helplessness. This is a 13 item questionnaire. Each question has five response options ranging from 0 (not at all) to 4 (all the time) scale, with a maximum score of 52

  4. Feasibility of collecting patient reported outcomes of anxiety as assessed by the General Anxiety Disorder-7 (GAD-7) questionnaire [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This is an 7 item questionnaire, each is scored from 0(not at all) to 3(nearly every day), a higher score indicating more anxiety

  5. Feasibility of collecting patient reported outcomes of depression as assessed by the Patient Health Questionnaire (PHQ-8) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This is an 8 item questionnaire.Each question is scored from 0 to 1 day = "not at all," 2 to 6 days = "several days," 7 to 11 days = "more than half the days," and 12 to 14 days = "nearly every day". Total score is determined by adding together the scores of each of the four items. Scores are rated as normal (0-2), mild (3-5), moderate (6-8), and severe (9-12).

  6. feasibility of collecting patient reported outcomes of mindfulness, as assessed by the Five Facet Mindfulness Questionnaire-15 (FFMQ-15) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This is a 15 item questionnaire, each is scored from 1(never or very rarely true) to 5(very often or always true) for a maximum score of 120, higher score indicating more mindfulness

  7. Feasibility of collecting patient reported outcomes of quality of life as assessed by the SCI-quality of life (QOL): Positive Affect and Well Being-Short Form (PAWB-SF) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This is a 10 item scale each scored from (1)never to (5)always, with a maximum score of 50 a higher number indicating a better outcome

  8. Feasibility of collecting perceived stress as assessed by the Perceived Stress Scale (PSS-4) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    A four-item scale , each is scored from 0(never) to 4(very often) for a maximum score of 16 a higher score indicating more stress

  9. Feasibility of collecting fatigue as assessed by the PROMIS Fatigue- Short Form 4a [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    Each question has five response options ranging in value from five (very poor) to one (very good), a higher number indicating more fatigue.XX

  10. Feasibility of collecting psychological inflexibility/experiential avoidance as assessed by the acceptance and Action Questionnaire (AAQ-2) [Baseline, post-intervention (6 weeks post-enrollment), and end of study (12 weeks post enrollment)]

    This contains 7 items and answers are given on a 7-point scale ranging from 1 (never true) to 7 (always true). High scores on the AAQ-2 are reflective of greater experiential avoidance and immobility, while low scores reflect greater acceptance and action.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Traumatic SCI of at least 6 months duration

  • Chronic pain [defined as pain lasting at least 3 months with a pain intensity rating of 4 or higher on a 10-point visual analog scale]

  • Understand spoken and written English sufficiently to provide informed consent

  • participate in the intervention and complete study surveys

Exclusion Criteria:
  • Lack of daily access to the internet using a smart phone or smart tablet

  • Cognitive impairment (determined by their inability to demonstrate comprehension of informed consent by correctly answering 4 out of 5 questions pertaining to the study)

  • Significant visual/hearing impairment that does not allow use of the MM app's audiovisual presentations or health education presentations on Ted-talk

  • Use of any kind of meditation more than once a week in the last 3 months

  • Inability to provide or obtain an email address for communication with study staff

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas Health Science Center at Houston Houston Texas United States 77030
2 TIRR Memorial Hermann Houston Texas United States 77030

Sponsors and Collaborators

  • The University of Texas Health Science Center, Houston
  • National Center for Complementary and Integrative Health (NCCIH)
  • Sam Houston State University
  • TIRR Memorial Hermann

Investigators

  • Principal Investigator: Radha Korupolu, MD, The University of Texas Health Science Center, Houston
  • Principal Investigator: Chelsea Ratcliff, PhD, Sam Houston State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Radha Korupolu, Associate Professor, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT05556057
Other Study ID Numbers:
  • HSC-MS-22-0035
First Posted:
Sep 27, 2022
Last Update Posted:
Jan 25, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2023